Author
Listed:
- Yu Adachi
(National Institute of Infectious Diseases)
- Keisuke Tonouchi
(National Institute of Infectious Diseases
Waseda University)
- Arnone Nithichanon
(National Institute of Infectious Diseases
Khon Kaen University)
- Masayuki Kuraoka
(Duke University)
- Akiko Watanabe
(Duke University)
- Ryo Shinnakasu
(Osaka University)
- Hideki Asanuma
(National Institute of Infectious Diseases
National Institute of Infectious Diseases)
- Akira Ainai
(National Institute of Infectious Diseases)
- Yusuke Ohmi
(Chubu University College of Life and Health Sciences)
- Takuya Yamamoto
(National Institutes of Biomedical Innovation, Health and Nutrition)
- Ken J. Ishii
(National Institutes of Biomedical Innovation, Health and Nutrition
The Institute of Medical Science, The University of Tokyo)
- Hideki Hasegawa
(National Institute of Infectious Diseases
National Institute of Infectious Diseases)
- Haruko Takeyama
(Waseda University)
- Ganjana Lertmemongkolchai
(Khon Kaen University)
- Tomohiro Kurosaki
(Osaka University
RIKEN Center for Integrative Medical Sciences)
- Manabu Ato
(National Institute of Infectious Diseases)
- Garnett Kelsoe
(Duke University
Human Vaccine Institute, Duke University)
- Yoshimasa Takahashi
(National Institute of Infectious Diseases)
Abstract
Germinal center (GC) B cells at viral replication sites acquire specificity to poorly immunogenic but conserved influenza hemagglutinin (HA) epitopes. Here, high-throughput epitope mapping of local GC B cells is used to identify conserved HA epitope selecting cross-reactive antibodies that mediate heterosubtypic protection. A distinct feature of this epitope is an occlusion in the naive trimeric HA structure that is exposed in the post-fusion HA structure to occur under low pH conditions during viral replication. Importantly, systemic immunization by the post-fusion HA antigen results in GC B cells targeting the occluded epitope, and induces a class of protective antibodies that have cross-group specificity and afford protection independent of virus neutralization activity. Furthermore, this class of broadly protective antibodies develops at late time points and persists. Our results identify a class of cross-protective antibodies that are selected at the viral replication site, and provide insights into vaccine strategies using the occluded epitope.
Suggested Citation
Yu Adachi & Keisuke Tonouchi & Arnone Nithichanon & Masayuki Kuraoka & Akiko Watanabe & Ryo Shinnakasu & Hideki Asanuma & Akira Ainai & Yusuke Ohmi & Takuya Yamamoto & Ken J. Ishii & Hideki Hasegawa &, 2019.
"Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies,"
Nature Communications, Nature, vol. 10(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11821-6
DOI: 10.1038/s41467-019-11821-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11821-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.